Preliminary study of the mechanism of isolinderalactone inhibiting the malignant behavior of bladder cancer
Isolinderalactone controls BC progression by inducing apoptosis, suggesting that ILL may be an effective drug for the treatment of BC.
Authors
- Haifeng Wang (ORCID: https://orcid.org/0000-0003-0360-1402)
- Wei Feng (ORCID: https://orcid.org/0000-0002-8096-2212)
- Yuxin Sun (ORCID: https://orcid.org/0000-0003-1193-3677)
- Hairong Wei (ORCID: https://orcid.org/0000-0002-3551-4998)
- Wenkai Xu
- Ying Lu (ORCID: https://orcid.org/0000-0002-3545-1026)
- Jun Xie (ORCID: https://orcid.org/0000-0001-6657-0880)
- Hongjin Shi
- Haole Xu
- Zhao Yang
- Qun Wang (ORCID: https://orcid.org/0000-0003-1014-8677)
Institutions
- Kunming Medical University (CN)
- Xinjiang Production and Construction Corps (CN)
- Tarim University (CN)
- Chengdu Second People's Hospital (CN)
- Beijing University of Chemical Technology (CN)
Publication Details
- Journal
- Current Urology
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1097/cu9.0000000000000259
- Citations
- 1
- Primary Topic
- Natural product bioactivities and synthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.23
Funders
- Kunming Medical University
- Fundamental Research Funds for the Central Universities